Secondary solid malignancies after high-grade glioma treatment in pediatric patients

Due to the poor survival in high-grade glioma (HGG), secondary solid malignancies (SSM) following pediatric HGG are scarce. The authors present the experience from the HIT-HGG database in Germany, Austria, and Switzerland. Five out of 1228 pediatric HGG patients developed a SSM following a latency o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Karremann, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 03 Aug 2015
In: Pediatric hematology and oncology
Year: 2015, Jahrgang: 32, Heft: 7, Pages: 467-473
ISSN:1521-0669
DOI:10.3109/08880018.2015.1050615
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.3109/08880018.2015.1050615
Verlag, Volltext: https://doi.org/10.3109/08880018.2015.1050615
Volltext
Verfasserangaben:Michael Karremann, Marion Hoffmann, Martin Benesch, Robert Kwiecien, André O. von Bueren, and Christof M. Kramm

MARC

LEADER 00000caa a2200000 c 4500
001 1568003536
003 DE-627
005 20220814064713.0
007 cr uuu---uuuuu
008 180201s2015 xx |||||o 00| ||eng c
024 7 |a 10.3109/08880018.2015.1050615  |2 doi 
035 |a (DE-627)1568003536 
035 |a (DE-576)498003531 
035 |a (DE-599)BSZ498003531 
035 |a (OCoLC)1340986319 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Karremann, Michael  |d 1975-  |e VerfasserIn  |0 (DE-588)129089192  |0 (DE-627)389523534  |0 (DE-576)166957968  |4 aut 
245 1 0 |a Secondary solid malignancies after high-grade glioma treatment in pediatric patients  |c Michael Karremann, Marion Hoffmann, Martin Benesch, Robert Kwiecien, André O. von Bueren, and Christof M. Kramm 
264 1 |c 03 Aug 2015 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.02.2018 
520 |a Due to the poor survival in high-grade glioma (HGG), secondary solid malignancies (SSM) following pediatric HGG are scarce. The authors present the experience from the HIT-HGG database in Germany, Austria, and Switzerland. Five out of 1228 pediatric HGG patients developed a SSM following a latency of 29-122 months from primary HGG diagnosis. In 4 patients, the SSM may be attributed to previous radiotherapy or a tumor predisposition syndrome, reflected by a markedly increased cumulative incidence rate of SSM in patients with tumor predisposition. Survival was devastating, since none of the patients survived beyond 18 months from SSM diagnosis. 
650 4 |a children 
650 4 |a glioblastoma 
650 4 |a high-grade glioma 
650 4 |a secondary solid malignancies 
773 0 8 |i Enthalten in  |t Pediatric hematology and oncology  |d Abingdon : Taylor & Francis Group, 1986  |g 32(2015), 7, Seite 467-473  |h Online-Ressource  |w (DE-627)320415120  |w (DE-600)2001806-X  |w (DE-576)090881036  |x 1521-0669  |7 nnas  |a Secondary solid malignancies after high-grade glioma treatment in pediatric patients 
773 1 8 |g volume:32  |g year:2015  |g number:7  |g pages:467-473  |g extent:7  |a Secondary solid malignancies after high-grade glioma treatment in pediatric patients 
856 4 0 |u http://dx.doi.org/10.3109/08880018.2015.1050615  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.3109/08880018.2015.1050615  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180201 
993 |a Article 
994 |a 2015 
998 |g 129089192  |a Karremann, Michael  |m 129089192:Karremann, Michael  |d 60000  |d 62300  |e 60000PK129089192  |e 62300PK129089192  |k 0/60000/  |k 1/60000/62300/  |p 1  |x j 
999 |a KXP-PPN1568003536  |e 299492207X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","family":"Karremann","display":"Karremann, Michael","given":"Michael"}],"language":["eng"],"note":["Gesehen am 01.02.2018"],"origin":[{"dateIssuedDisp":"03 Aug 2015","dateIssuedKey":"2015"}],"name":{"displayForm":["Michael Karremann, Marion Hoffmann, Martin Benesch, Robert Kwiecien, André O. von Bueren, and Christof M. Kramm"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1568003536"],"doi":["10.3109/08880018.2015.1050615"]},"recId":"1568003536","title":[{"title_sort":"Secondary solid malignancies after high-grade glioma treatment in pediatric patients","title":"Secondary solid malignancies after high-grade glioma treatment in pediatric patients"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"pubHistory":["3.1986 -"],"note":["Gesehen am 04.09.15"],"titleAlt":[{"title":"International journal of pediatric hematology/oncology"},{"title":"Pediatric hematology and oncology incorporating the International journal of pediatric hematology/oncology"}],"language":["eng"],"recId":"320415120","id":{"issn":["1521-0669"],"eki":["320415120"],"zdb":["2001806-X"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Secondary solid malignancies after high-grade glioma treatment in pediatric patientsPediatric hematology and oncology","origin":[{"publisher":"Taylor & Francis Group ; Informa Healthcare, Taylor & Francis Group","dateIssuedDisp":"1986-","publisherPlace":"Abingdon ; London [u.a.]","dateIssuedKey":"1986"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Pediatric hematology and oncology","title":"Pediatric hematology and oncology"}],"part":{"volume":"32","text":"32(2015), 7, Seite 467-473","extent":"7","issue":"7","pages":"467-473","year":"2015"}}]} 
SRT |a KARREMANNMSECONDARYS0320